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In an attempt to explain the high resistance of is not consistent with regard to the preventive ef- 
the immature brain to hypoxic/ischemic damage fects of taurine on ischemic heart failure [3,4]. It 
and the increased resistance of brain tissue is essential that much more data are acquired on 
repeatedly exposed to hypoxia, Schurr and Rigor this controversial issue before a meaningful 
[l] propose that production of hypotaurine and hypothesis can be presented. To support their 
taurine is of critical importance. Hypotheses are ideas, the authors list the ample literature on phar- 
based on speculation upon established facts. macological effects of taurine on calcium 
However, in our opinion, the crucial points on metabolism. It should be noted that there is so far 
which the present hypothesis rests are in conflict no evidence for a (patho)physiological role for 
with it. taurine as a calcium modulator. 
The main feature of the hypothesis is that 
taurine protects the brain and possibly other 
organs from ischemic injury by interfering with 
cellular calcium accumulation. The high levels of 
taurine in the brain of the neonate would conse- 
quently underlie the tolerance to anoxia. Further, 
it is suggested that cysteine and cysteamine are 
formed during ischemia and are converted to cys- 
teine sulfinate, cysteate and hypotaurine in the 
deoxygenation period. These taurine precursors 
are claimed to scavenge deleterious free oxygen 
radicals and to be metabolized into taurine, 
thereby increasing the tissue levels of the amino 
acid. It is important to point out that the evidence 
that taurine protects brain tissue against anoxia is 
at present limited to one single report [2]. 
However, taurine does not protect the immature 
rat hippocampal slice against anoxic injury as 
evaluated morphologically (Ellren, Andine, 
Hagberg and Lehmann, in preparation). There is 
no evidence for a neuroprotective ffect of taurine 
against ischemia in vivo. Moreover, the literature 
The key issue of the hypothesis is whether tissue 
taurine concentrations increase post-hypoxia, and 
the authors appear to misinterpret our results [5] in 
this respect. Extracellular taurine increases during 
cerebral ischemia but is normalized upon reperfu- 
sion. However, this effect is not a reflection of 
elevated intracellular levels, but rather of condi- 
tions that favor an intra- to extracellular shift of 
taurine distribution, namely depolarization com- 
bined with reduced reuptake (intra-/extracellular 
concentration ratio is approx. 300 for taurine) [5]. 
Most importantly, tissue taurine levels are 
remarkably stable in the brain during [5-71 and 
after [5,6] ischemia which contradicts the proposal 
of Schurr and Rigor [l]. Taurine is highly concen- 
trated in heart muscle fibers from which it is re- 
leased during ischemia [8]. In contrast to the 
situation during cerebral ischemia, cardiac ische- 
mia is accompanied by a net loss of taurine [8], 
which is in disagreement with the hypothesis. 
Moreover, mice adapted to hypoxia show no 
changes in heart levels of taurine [9]. 
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The fact that cerebral taurine decreases 
postnatally in parallel with increased sensitivity to 
hypoxia may be coincidental, and a number of 
similar positive or negative correlations can be 
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found (e.g. maturation of excitatory amino acid 
transmitter systems). Moreover, although the 
developmental pattern of changes in cerebral 
taurine is well-known, there is a paucity on infor- 
mation on the exact timing of increased sensitivity 
to ischemia. We are not aware of any reports 
showing significant elevation of cysteine or 
cysteamine in the brain during hypoxia. Besides, 
the cysteamine pathway for taurine biosynthesis 
has not been found in the central nervous system 
[lo]. Again, these are lateral questions as taurine 
does not increase in the reperfusion phase. The 
possibility that an accelerated synthesis is masked 
by an increased degradation of taurine is unlikely 
since there is no quantitatively important 
breakdown of taurine in mammals [l I]. 
In summary, the hypothesis of Schurr and Rigor 
[l] is not in harmony with established facts and it 
seems premature to suggest that endogenous 
taurine has a protective function in ischemic brain 
damage. 
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